Article
In silico analysis of the wild-type and mutant-type of BRCA2 gene.
Journal of translational medicine - 21 May 2024
Li Jingjing, Ge Rui, Lu Guanming, Cai Yuanxuan, Teng Yuan, Fan Zhe, Liao Liangyan, Kong Lingjie, Zhang Jinze, Wei Tao, Li Qian, Long Tianzhu, Yu Hongyan, Li Jie
Abstract excerpt
BACKGROUND: The aim of this study was to conduct an in silico analysis of a novel compound heterozygous variant in breast cancer susceptibility gene 2 (BRCA2) to clarify its structure-function relationship and elucidate the molecular mechanisms underlying triple-negative breast cancer (TNBC). METHODS: A tumor biopsy sample was obtained from a 42-year-old Chinese woman during surgery, and a maxBRCA™ test was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
